These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

42 related articles for article (PubMed ID: 1673615)

  • 1. Studies on DNA sequence specific binding proteins for 5' flanking upstream region of CPSI gene.
    Hong Y; Wang Z; Li SE
    Sci China B; 1991 Feb; 34(2):194-200. PubMed ID: 1673615
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Expression of rat CPSI full-length cDNA gene in non-liver culture cells].
    Niu B
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1993 Oct; 15(5):313-9. PubMed ID: 8168212
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Involvement of a cis-acting element in the suppression of carbamoyl phosphate synthetase I gene expression in the liver of carnitine-deficient mice.
    Abdullah Abu Musa DM; Kobayashi K; Yasuda I; Iijima M; Christoffels VM; Tomomura M; Horiuchi M; Ohnishi T; Kajihara T; Daikuhara Y; Lamers WH; Saheki T
    Mol Genet Metab; 1999 Nov; 68(3):346-56. PubMed ID: 10562461
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural requirements of the glucocorticoid-response unit of the carbamoyl-phosphate synthase gene.
    Schoneveld OJ; Gaemers IC; Das AT; Hoogenkamp M; Renes J; Ruijter JM; Lamers WH
    Biochem J; 2004 Sep; 382(Pt 2):463-70. PubMed ID: 15196051
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatocyte-specific interplay of transcription factors at the far-upstream enhancer of the carbamoylphosphate synthetase gene upon glucocorticoid induction.
    Hoogenkamp M; Gaemers IC; Schoneveld OJ; Das AT; Grange T; Lamers WH
    FEBS J; 2007 Jan; 274(1):37-45. PubMed ID: 17140418
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Construction of the mammalian expression systems in hepatoma and non-liver cells with rat CPSI cDNA fragments].
    Niu B; Wang Z; Xiang Q
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1994 Oct; 16(5):361-5. PubMed ID: 7720128
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Upstream region of rat serum albumin gene promoter contributes to promoter activity: presence of functional binding site for hepatocyte nuclear factor-3.
    Hsiang CH; Marten NW; Straus DS
    Biochem J; 1999 Mar; 338 ( Pt 2)(Pt 2):241-9. PubMed ID: 10024498
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Functional analysis of the CPS I upstream sequences with a CAT assay].
    Niu B; Wang Z; Yu Y; Wang M; Zeng S
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1995 Apr; 17(2):92-7. PubMed ID: 7656402
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cell-specific expression of AFP gene is dependent on some nuclear proteins].
    Liu HH; Shen QX; Guo LH
    Shi Yan Sheng Wu Xue Bao; 1995 Jun; 28(2):157-62. PubMed ID: 7571950
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cloning, sequencing, and functional analysis of the 5'-flanking region of the rat 3 alpha-hydroxysteroid/dihydrodiol dehydrogenase gene.
    Lin HK; Penning TM
    Cancer Res; 1995 Sep; 55(18):4105-13. PubMed ID: 7664287
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in cyclic adenosine monophosphate-responsive element binding proteins in rat hepatomas.
    Kwast-Welfeld J; de Belle I; Walker PR; Isaacs RJ; Whitfield JF; Sikorska M
    Cancer Res; 1991 Jan; 51(2):528-35. PubMed ID: 1824683
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin 6 response factor binds co-operatively at two adjacent sites in the promoter upstream region of the rat alpha 2-macroglobulin gene.
    Brechner T; Hocke G; Goel A; Fey GH
    Mol Biol Med; 1991 Apr; 8(2):267-85. PubMed ID: 1725449
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular characterization of the promoter region of a neuroendocrine tumor marker, IA-1.
    Li Q; Notkins AL; Lan MS
    Biochem Biophys Res Commun; 1997 Jul; 236(3):776-81. PubMed ID: 9245732
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Preliminary analysis of the 5'-flanking region of rat gamma-glutamylcysteine synthetase catalytic subunit gene].
    Cheng LL; Li B; Tu HB; Liu QC; Ran PX
    Zhonghua Jie He He Hu Xi Za Zhi; 2005 Mar; 28(3):164-8. PubMed ID: 15854410
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo footprinting of the carbamoylphosphate synthetase I cAMP-response unit indicates important roles for FoxA and PKA in formation of the enhanceosome.
    Hoogenkamp M; Stallen JM; Lamers WH; Gaemers IC
    Biochimie; 2006 Oct; 88(10):1357-66. PubMed ID: 16824661
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sequencing and characterization of the human thiazide-sensitive Na-Cl cotransporter (SLC12A3) gene promoter.
    MacKenzie S; Vaitkevicius H; Lockette W
    Biochem Biophys Res Commun; 2001 Apr; 282(4):991-1000. PubMed ID: 11352650
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cloning and sequence of a cDNA encoding human carbamyl phosphate synthetase I: molecular analysis of hyperammonemia.
    Haraguchi Y; Uchino T; Takiguchi M; Endo F; Mori M; Matsuda I
    Gene; 1991 Nov; 107(2):335-40. PubMed ID: 1840546
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of genomic structure and polymorphisms in the human carbamyl phosphate synthetase I gene.
    Summar ML; Hall LD; Eeds AM; Hutcheson HB; Kuo AN; Willis AS; Rubio V; Arvin MK; Schofield JP; Dawson EP
    Gene; 2003 Jun; 311():51-7. PubMed ID: 12853138
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rat carbamyl-phosphate synthetase I gene. Promoter sequence and tissue-specific transcriptional regulation in vitro.
    Lagacé M; Howell BW; Burak R; Lusty CJ; Shore GC
    J Biol Chem; 1987 Aug; 262(22):10415-8. PubMed ID: 3038878
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activity of the carbamyl phosphate synthetase I promoter in liver nuclear extracts is dependent on a cis-acting C/EBP recognition element.
    Howell BW; Lagacé M; Shore GC
    Mol Cell Biol; 1989 Jul; 9(7):2928-33. PubMed ID: 2476660
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.